Concepedia
Statistics
Publications
79
Citations
5K
H-Index
35
Active since
1985
Affiliations
Roche (Switzerland)(Current)
Roche (France)
Inserm
Genoscience Pharma (France)
Certara (United States)
René Bruno is an author at Roche (Switzerland) specializing in pharmacology, oncology, and pharmacokinetics.
Publications per year
1985–2024
Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.
René Bruno, Darcy A. Hille, A. Riva et al. · Journal of Clinical Oncology · 1998 · 423 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
Clinical pharmacokinetics of bevacizumab in patients with solid tumors
Jianfeng Lü, René Bruno, Steve Eppler et al. · Cancer Chemotherapy and Pharmacology · 2008 · 346 citations
Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +14
Model-Based Prediction of Phase III Overall Survival in Colorectal Cancer on the Basis of Phase II Tumor Dynamics
Laurent Claret, Pascal Girard, Paulo M. Hoff et al. · Journal of Clinical Oncology · 2009 · 271 citations · Full text
Medicine, Oncology, Pharmacology +17
A population pharmacokinetic model for docetaxel (Taxotere®): Model building and validation
René Bruno, Nicole Vivier, J. Vergniol et al. · Journal of Pharmacokinetics and Biopharmaceutics · 1996 · 265 citations
Pharmacy, Pharmacokinetics, Pharmacology +14
Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion.
Jean Marc Extra, Frédérique Rousseau, René Bruno et al. · PubMed · 1993 · 253 citations
Medicine, Oncology, Pharmacology +14
1–5 of 79